Subjects | Total number | Number of males | Number of females | Mean age (Years) | Age range (years) |
---|---|---|---|---|---|
(A) Tissue samples | |||||
Total GBC Cases | 7 | 0 | 7 | 50.86 | 30–66 |
Stages | |||||
 GBC, Stage I | 1 | 0 | 1 | 38 | 38 |
 GBC, Stage II | 1 | 0 | 1 | 65 | 65 |
 GBC, Stage IIIA | 5 | 0 | 5 | 50.6 | 30–66 |
Histological grade | |||||
 Well-differentiated (G1) | 1 | 0 | 1 | – | – |
 Moderately-differentiated (G2) | 4 | 0 | 4 | – | – |
 Poorly-differentiated (G3) | 2 | 0 | 2 | – | – |
(B) Plasma samples | |||||
Total GBC Cases | 52 | 10 | 42 | 50.88 | 22–78 |
Stages | |||||
 GBC, Stage I | 6 | 1 | 5 | 39.66 | 22–47 |
 GBC, Stage II | 6 | 1 | 5 | 52.16 | 34–66 |
 GBC, Stage III | 17 | 2 | 15 | 52.76 | 30–66 |
 GBC, Stage IV | 23 | 6 | 17 | 52.08 | 38–78 |
 Early Stages (I and II) | 12 | 2 | 10 | 45.91 | 22–66 |
 Advanced stages (III and IV) | 40 | 8 | 32 | 52.37 | 30–78 |
LN status | |||||
 LN negative | 23 | 2 | 21 | 48.91 | 22–66 |
 LN positive | 29 | 8 | 21 | 52.44 | 38–78 |
Histological grade | |||||
 Well-differentiated (G1) | 5 | 0 | 5 | – | – |
 Moderately-differentiated (G2) | 32 | 5 | 27 | – | – |
 Poorly-differentiated (G3) | 15 | 2 | 13 | – | – |
Total Controls | 89 | 28 | 61 | 40.89 | 20–72 |
GSD cases | 48 | 13 | 35 | 43.06 | 20–72 |
Healthy group | 41 | 15 | 26 | 38.36 | 24–59 |